SCHEMBL2597725

SCHEMBL2597725

CCOC(=O)C(C(=O)OCC)c1ccc(N)c(C(=O)N(C)C)c1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
HSD17B10 Q99714 2/20 0.41
MAP4K1 Q92918 11/20 0.41
CYP3A4 P08684 2/20 0.40
ABL1 P00519 1/20 0.40
MMP8 P22894 1/20 0.38
GAA P10253 2/20 0.35
KDM4E B2RXH2 2/20 0.34
HSP90AA1 P07900 1/20 0.34
HSP90AB1 P08238 1/20 0.34
HTT P42858 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
ALOX15 P16050 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11920717 0.79 MMP8 (0.43) ALDH1A1HSD17B10CYP3A4MMP8KDM4E
SCHEMBL2597715 0.79 KMT2A (0.41) ALDH1A1GAAKDM4EHSP90AA1HTT
SCHEMBL2297081 0.77 MMP8 (0.41) ALDH1A1HSD17B10CYP3A4MMP8GAA
SCHEMBL17653867 0.75 CA12 (0.44) ALDH1A1HSD17B10CYP3A4MMP8GAA
SCHEMBL2597790 0.74 AKR1C3 (0.44) MAP4K1MEN1KMT2AMAPTHPGD
SCHEMBL2745486 0.73 AR (0.40) ALDH1A1MMP8MEN1KMT2A
SCHEMBL400213 0.73 CYP4F2 (0.51) ALDH1A1HSD17B10MAP4K1CYP3A4ABL1
SCHEMBL271585 0.73 MMP8 (0.59) ALDH1A1HSD17B10CYP3A4MMP8HTT
SCHEMBL3806699 0.72 MAPT (0.51) ALDH1A1HSD17B10MAP4K1CYP3A4ABL1
SCHEMBL1041487 0.72 LMNA (0.56) ALDH1A1HSD17B10CYP3A4MMP8GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2571860-A1 2-PHENYL BENZOYLAMIDES Pfizer Inc (US) 2013-03-27 EP disclosed
US-20130072519-A1 2-PHENYL BENZOYLAMIDES CONN EDWARD LEE (US) 2013-03-21 US disclosed
US-20130072519-A1 2-PHENYL BENZOYLAMIDES CONN EDWARD LEE (US) 2013-03-21 US disclosed
WO-2011145022-A1 2-PHENYL BENZOYLAMIDES PFIZER INC. (US) 2011-11-24 WO disclosed
WO-2011145022-A1 2-PHENYL BENZOYLAMIDES PFIZER INC. (US) 2011-11-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130072519-A1 2-PHENYL BENZOYLAMIDES APOB, MTTP, HADHB ALDH1A1 885/4885HSD17B10 191/4885MAP4K1 3774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.